Arrambide, G.
54  results:
Search for persons X
?
2

Significant clinical worsening after natalizumab withdrawal..:

Vidal-Jordana, A ; Tintoré, M ; Tur, C...
Multiple Sclerosis Journal.  21 (2014)  6 - p. 780-785 , 2014
 
?
 
?
 
?
7

PO10-TU-44 Use of monthly cyclophosphamide and methylpredni..:

Flores-Rivera, J. ; Arrambide, G. ; Mendoza, G..
Journal of the Neurological Sciences.  285 (2009)  - p. S207 , 2009
 
?
8

Spectroscopic Behavior and Biological Activity of K3[VO(O2)..:

Arrambide, G. ; Rivadeneira, J. ; Etcheverry, S. B....
Biological Trace Element Research.  132 (2009)  1-3 - p. 176-183 , 2009
 
?
 
?
10

Differential diagnosis of suspected multiple sclerosis: an ..:

Solomon, AJ ; Arrambide, G ; Brownlee, WJ...
https://discovery.ucl.ac.uk/id/eprint/10174655/2/Solomon_Differential%20diagnosis%20of%20suspected%20multiple%20sclerosis-%20an%20updated%20consensus%20approach_AAM.pdf.  , 2023
 
?
13

Cerebrospinal fluid kappa free light chains for the diagnos..:

Hegen, H ; Walde, J ; Berek, K...
https://discovery.ucl.ac.uk/id/eprint/10164252/2/Zetterberg_Hegen.pdf.  , 2022
 
?
14

Cerebrospinal fluid kappa free light chains for the diagnos..:

Hegen, H ; Arrambide, G ; Gnanapavan, S...
https://discovery.ucl.ac.uk/id/eprint/10162458/1/13524585221134217.pdf.  , 2022
 
1-15